Meet with Ontada
at ASCO Annual Meeting 2026
May 29 - June 2 | Chicago
VISIT US AT BOOTH 30123
We look forward to connecting with you at ASCO in Chicago. To meet with us at ASCO and learn more about Ontada's real-world data, provider education and research offerings, fill out the form or stop by the McKesson/Ontada Booth #30123 to chat.
For information about our research being presented, simply scroll down on this page.
To learn about our podium presentation, 5 posters and 8 online articles, scroll down.
ASCO 2026 presentations
GLP-1 receptor agonist utilization and survival outcomes in a large U.S. community oncology cohort
Rapid Oral Abstract Session —
Quality Care/Health Services Research
Saturday, May 30, 3:00 - 4:30 p.m.
Presentation Time: 4:12 p.m. – 4:18 p.m.
Presenter: Jessica K. Paulus
Authors: Ila Sruti, Chuck Wentworth, Ari Marcus, Zhaohui Su, Jessica K. Paulus
Racial variation in pain medication prescriptions among breast, prostate, and pancreatic cancer patients treated in a large community oncology setting
Saturday, May 30, 9:00 am – 12:00 p.m.
Presenter: Ila Sruti
Authors: Ila Sruti, Zhaohui Su, Robert Reid, Jessica K. Paulus
Poster Board: 568
Early-onset gastrointestinal cancers: Racial disparities in stage and survival from large-scale community oncology data
Saturday, May 30, 9:00 – 12:00 p.m.
Presenter: Jessica K. Paulus
Authors: Saamir Pasha, Janet Espirito, Jinhong Guo, Robert Reid, Jessica K. Paulus
Real-World Characteristics, Homologous Recombination Repair Mutation (HRRm) Testing, Treatment Patterns and Outcomes of Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC) in the US Community Oncology Setting
Sunday, May 31, 9:00 – 12:00 p.m.
Presenter: TBA
Authors: Manojkumar Bupathi, Andrew J. Osterland, Suvina Amin, Saamir Pasha, Wei Dai, Melissa Kirker, Neo Su, Saif Shaman, Benjamin Li, Sandra T. Asanin, Sarah Hanson, Gregory Patton
Poster Board: 175
Treatment patterns and PD-L1 testing among persistent, recurrent, or metastatic cervical cancer patients in the United States community oncology setting
Monday, June 1, 9:00 a.m. – 12:00 p.m.
Presenter: Ila Sruti
Authors: Elizabeth Szamreta, Ila Sruti, Gregory Patton, Jinhong Guo, Chuck Wentworth, Audrey Garrett
Poster Board: 188
Radiotherapy use among locally advanced cervical cancer patients (LACC) in the United States community oncology setting
Monday, June 1, 9:00 a.m. – 12:00 p.m.
Presenter: Ila Sruti
Authors: Elizabeth Szamreta, Ila Sruti, Gregory Patton, Jinhong Guo, Chuck Wentworth, Audrey Garrett
Poster Board: 189
Real-world clinical outcomes for neoadjuvant pembrolizumab among patients with early-stage triple-negative breast cancer (esTNBC) in a US community oncology setting
Authors: Amin Haiderali, Wilbur Pan, Michael Danso, Ila Sruti, Saamir Pasha, Divea Venkatasetty, Paul Conkling
Real-world Treatment Patterns and Outcomes of Early-stage Renal Cell Carcinoma Patients Receiving Adjuvant Pembrolizumab Treatment
Authors: Reshma Shinde, Sneha Sura, Murali Sudaram, Karen Todoroff, Joseph Burgents, Ira Zackon
Diagnostic Efficiency in Precision Oncology: Quantifying Time to Treatment Initiation for Biomarker-Positive vs. Biomarker-Negative Metastatic NSCLC
Authors: Zhaohui Su, Karen Todoroff, Robert Reid
A US Real-world Study of Second-Line Outcomes in Advanced Ovarian Cancer by First-Line PARP Inhibitor Maintenance Exposure
Authors: Lei Chen, Sneha Sura, Jelinic Petar, Elizabeth Anne Szamreta, Gregory Patton, Peter Wang, John Murphy, Audrey P Garrett
Real‑world characteristics, treatment patterns, and outcomes of newly diagnosed diffuse large B‑cell lymphoma (DLBCL) patients treated in first-line (1L) in the United States
Authors: Anna Teschemaker, Helen Latimer, Barbara Furtado, Marc Purazo, Debbie Adkins, Ira Zackon, Jinhong Guo, Helen Engle,
David Andorsky
Mapping the treatment journey following antibody-drug conjugate (ADC) initiation: sequencing patterns and real world overall survival (rwOS) in non-breast solid tumors in US community setting
Authors: Changxia Shao, Alisha Monnette Kimble, Juliet Ndukum, Thomas A. Burke, Peter Kaskel, Senaka A. Peter, Yue Shentu,
Anne C. Deitz, Tanya Elizabeth Keenan, Fan Jin, Robert Reid
Real-world (rw) study of the treatment journey following antibody-drug conjugate (ADC) initiation and overall survival (OS) in breast cancer (BC) in a US community setting
Authors: Changxia Shao, Alisha Monnette Kimble, Juliet Ndukum, Thomas A. Burke, Peter Kaskel, Thao Vo, Yue Shentu,
Nina Balanchivadze, Anne C. Deitz, Kim M. Hirshfield, Fan Jin, Tanya Elizabeth Keenan, Robert Lawrence Reid
Validation of a treatment-based algorithm to infer biomarker status in real-world data
Authors: Cherrishe Brown-Bickerstaff, Saamir Pasha, Lauren Stevens, Robert Reid
Meet Our Team at ASCO 2026
Reach out to our team for an ASCO meetup or fill out our form. We look forward to seeing you in Chicago!